Skip to main content
All lobbying filings

KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC

Lobbying for CVS HEALTH · ​Pharmacy innovation and healthcare

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 15, 2026

Official filing document

 Lobbying activity 2
Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem